Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Publication year range
1.
Environ Sci Pollut Res Int ; 28(42): 59665-59672, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34142322

ABSTRACT

The red imported fire ant is one of the world's most devastating invasive species, adversely affecting humans, wildlife, crops, and livestock. To control infestations, chemical pesticides are deployed extensively around the world. However, their extensive use has led to negative effects on the environment and human health. Essential oils, which are safe and ecofriendly, can potentially be used as alternatives to chemical pesticides. In this study, grapefruit essential oils were used as fumigant agents to control red imported fire ants. The crude grapefruit oil (GO1) contained 28 compounds, and the concentrated grapefruit oil (GO2), which was refined from GO1 by vacuum distillation, contained 20 compounds. D-Limonene was the dominant constituent in both GO1 (70.1%) and GO2 (73.96%), and other important constituents included ß-pinene, α-pinene, ß-phellandrene, octanal, d-carvone, α-terpineol, and linalool. Both the essential oils and their individual constituents (α-pinene, α-terpineol, ß-phellandrene, octanal, and d-carvone) showed strong lethal fumigant effects against workers. Workers were more susceptible to GO2 than GO1, and octanal was more toxic to workers as compared with the other four constituents. When antennas of workers were treated with the two oils or the five constituents, their walking and gripping abilities were significantly suppressed, and there was an obvious bending or breaking phenomenon on the sensilla of the antennas. Fumigant activity by grapefruit essential oils and their main compounds were associated with their effects on the walking and gripping behavior of workers, and this confirmed that grapefruit essential oil is a promising, ecofriendly, and safe fumigant for the control of red imported fire ants.


Subject(s)
Ants , Citrus paradisi , Oils, Volatile , Pesticides , Animals , Plant Oils
2.
Can J Physiol Pharmacol ; 96(12): 1286-1292, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30326192

ABSTRACT

Peripheral neuropathic condition is amongst the classical symptoms of progressed diabetes. An intensive glycemic control with insulin injections has been shown to delay the onset and the progression of this condition in diabetes. In this study, we investigated the effect of pectin-insulin patch application on peripheral neuropathic symptoms in streptozotocin-induced diabetic rats. Pectin-insulin patches (20.0, 40.8, and 82.9 µg/kg) were daily applied thrice in streptozotocin-induced diabetic rats for 45 days. The diabetic animals sham treated with insulin-free patch served as negative control, while diabetic animals receiving subcutaneous insulin served as positive controls. The locomotor activity, gripping strength, and thermal perception were assessed at day 36, day 40, and day 44, respectively. On the 45th day, the animals were sacrificed, after which the plasma insulin, nitric oxide, C-reactive protein, tumor necrosis factor alpha, and malondialdehyde were measured. The patch application attenuated hyperglycemia with an improvement in the locomotor activity, thermal perception, and gripping strength in diabetic animals. Furthermore, the application of the patch augmented plasma nitric oxide while attenuating plasma malondialdehyde and tumor necrosis factor alpha. The application of pectin-insulin patch delays the onset of peripheral neuropathic-like symptoms in diabetic animals.


Subject(s)
Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/complications , Insulin/administration & dosage , Pectins/administration & dosage , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/etiology , Streptozocin/pharmacology , Animals , Disease Models, Animal , Disease Progression , Hand Strength , Locomotion/drug effects , Male , Malondialdehyde/metabolism , Muscle Strength/drug effects , Nitric Oxide/metabolism , Rats , Rats, Sprague-Dawley , Transdermal Patch , Tumor Necrosis Factor-alpha/metabolism
3.
Life Sci ; 107(1-2): 32-41, 2014 Jun 27.
Article in English | MEDLINE | ID: mdl-24802126

ABSTRACT

AIMS: Obesity and insulin resistance are associated with increased oxidant stress. However, treatments of obese subjects with different types of antioxidants often give mixed outcomes. In this work, we sought to determine if long-term supplementation of a thiol antioxidant, ß-mercaptoethanol, to diet-induced obese mice may improve their health conditions. MAIN METHODS: Middle-age mice with pre-existing diet-induced obesity were provided with low concentration ß-mercaptoethanol (BME) in drinking water for six months. Animals were assessed for body composition, gripping strength, spontaneous physical and metabolic activities, as well as insulin and pyruvate tolerance tests. Markers of inflammation were assessed in plasma, fat tissue, and liver. KEY FINDINGS: BME-treated mice gained less fat mass and more lean mass than the control animals. They also showed increased nocturnal locomotion and respiration, as well as greater gripping strength. BME reduced plasma lipid peroxidation, decreased abdominal fat tissue inflammation, reduced fat infiltration into muscle and liver, and reduced liver and plasma C-reactive protein. However, BME was found to desensitize insulin signaling in vivo, an effect also confirmed by in vitro experiments. SIGNIFICANCE: Long-term supplementation of low dose thiol antioxidant BME improved functional outcomes in animals with pre-existing obesity. Additional studies are needed to address the treatment impact on insulin sensitivity if a therapeutic value is to be explored.


Subject(s)
Antioxidants/pharmacology , Body Composition/drug effects , Mercaptoethanol/pharmacology , Obesity/drug therapy , Adipokines/blood , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Animals , C-Reactive Protein/metabolism , Diet, High-Fat , Dietary Supplements , Hep G2 Cells , Humans , Inflammation/chemically induced , Inflammation/drug therapy , Insulin/metabolism , Insulin Resistance , Lipid Peroxidation , Liver/drug effects , Locomotion/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Obese , Muscle, Skeletal/drug effects , Obesity/metabolism , Pyruvic Acid/metabolism , Respiration/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL